ÇBÇağdaş Buluş

Çağdaş Buluş

*This is an algorithmically generated author record based on publicly available information.

Çağdaş Buluş has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identifying a Cardio‐Hepatic Phenotype by Integrating the Albumin‐Bilirubin Score Into Risk Assessment in Pulmonary Arterial Hypertension

    by Hacer Ceren Tokgoz, Barkin Kultursay, Seda Tanyeri, Dicle Sırma, Cagdas Bulus, Tezel Kovanci, Mustafa Kara, Seyma Zeynep Atici, Seyma Nur Cicek, Caglar Emre Cagliyan, et al.

    Risk stratification is essential in pulmonary arterial hypertension (PAH), yet the prognostic utility of the albumin‐bilirubin (ALBI) score as a marker of hepatic dysfunction remains underexplored. In this single‐center study, we evaluated the clinical, neurohumoral, echocardiographic and hemodynamic correlates and prognostic value of the ALBI score, and to assess whether this score offers an incremental benefit over the Registry to EValuate Early And Long‐term pulmonary arterial hypertension disease management (REVEAL) 2.0 risk score in patients with PAH. This study evaluated the prognostic value of the ALBI score and its incremental benefit in a cohort of 380 PAH patients (mean age 47.6 ± 18.3 years, 74.3% female). Patients were stratified into low (<= −2.60) and high (> −2.60) ALBI groups. High ALBI scores were significantly associated with worse functional class, reduced exercise capacity, elevated Nt‐proBNP, right ventricular systolic dysfunction, and vena cava plethora (all p  < 0.001). Hemodynamically, elevated ALBI correlated with increased right atrial pressure (RAP) ( p  = 0.005), reduced cardiac index ( p  = 0.002), and a narrowed trans‐systemic pressure gradient ( p  = 0.001). Multivariable Cox regression demonstrated that ALBI was an independent predictor of mortality [Adjusted HR: 1.80 (95% CI: 1.30–2.49), p  < 0.001], outperforming MELD variants and the FIB‐4 index. Integrating ALBI into REVEAL 2.0 yielded higher risk discrimination (C‐index: 0.756) than adding direct echocardiographic indices of right ventricular function or coupling (C‐indices: 0.748–0.749). In sensitivity analyses adjusting for TAPSE/PASP, invasive cardiac index, mean RAP, and background therapy, ALBI maintained its independent prognostic value [Adjusted HR: 1.44 (95% CI: 1.01–2.05), p  = 0.044], with the full model achieving a C‐index of 0.801. Within the REVEAL 2.0 intermediate‐risk subgroup, a high ALBI score identified patients with a three‐fold higher mortality risk [HR: 3.04 (95% CI: 1.25–7.38), p  = 0.014], improving discriminative performance by 26.3%. The ALBI score independently predicts mortality beyond standard pulmonary hemodynamics and echocardiographic right ventricular parameters. Incorporating ALBI into REVEAL 2.0 enhances survival prediction and aids risk refinement in intermediate‐risk PAH.

  • Open Access

    Phenotypic Clustering of Idiopathic Pulmonary Arterial Hypertension: Insights Into Pulmonary Vascular and Cardiometabolic Co‐Morbidity Trajectories

    by Cihangir Kaymaz, Barkin Kultursay, Hacer Ceren Tokgoz, Seda Tanyeri, Cagdas Bulus, Berhan Keskin, Caglar Emre Cagliyan, Metehan Kibar, Can Erdem, Aziz Vezir, et al.

    Idiopathic pulmonary arterial hypertension (IPAH) exhibits significant clinical heterogeneity, necessitating a precision medicine approach. This study aimed to identify distinct IPAH phenotypes using machine learning‐based clustering and to evaluate their longitudinal therapeutic responses and long‐term survival. We analyzed 297 IPAH patients using hierarchical agglomerative clustering based on baseline demographics, hemodynamics, and comorbidities. The cohort was characterized by two distinctive yet overlapping phenotypic patterns: Cluster 1 ( n = 198, “Pulmonary Vascular Phenotype”), comprising younger patients (median age: 40) with low comorbidity burden but severe hemodynamic impairment, and Cluster 2 ( n = 99, “Cardiometabolic Phenotype”), consisting of older, predominantly female patients (median age: 65) with high prevalence of obesity (78%), diabetes (73%), and hypertension (57%). Despite comparable baseline multiparametric risk scores, Cluster 1 exhibited more impaired echocardiographic right ventricular‐arterial coupling, lower left ventricular filling pressure and higher pulmonary vascular resistance ( p < 0.001). Triple combination therapy was significantly more frequent in Cluster 1 (41.6% vs. 25.5%, p = 0.048). Linear mixed‐effects modeling over 12 months demonstrated that Cluster 1 achieved superior functional recovery (6‐min walk distance increase: 75 m vs. 42 m, p < 0.001) and more profound neurohormonal stabilization (Final NT‐proBNP: 55 vs. 145 pg/mL, p = 0.017). However, during a median follow‐up of 763 days, 5‐year survival was similar between groups (Log‐rank p = 0.452), and cluster membership was not associated with mortality in adjusted Cox regression (HR: 0.71; 95% CI: 0.47–1.07; p = 0.099). These findings suggest that while vascular phenotypes demonstrate more robust responses to therapy, mortality is driven by distinct factors—hemodynamic severity in younger patients versus metabolic frailty in the comorbid population.


  • Open Access

    Data-driven phenotyping of infective endocarditis using unsupervised machine learning: toward a personalized approach

    by Murat Karaçam, Vedat Cicek, Barkın Kültürsay, Almina Erdem, Seda Tanyeri Üzel, Şeref Berk Tuncer, Tezel Kovancı, Feryat İgIt, Çağdaş Bulus, Mert Babaoğlu, et al.

    Infective endocarditis (IE) is a heterogeneous disease with diverse clinical presentations, microbiological profiles, and outcomes. Conventional classifica

  • Open Access

    Prognostic and functional value of left atrial indices in advanced heart failure

    by Murat Karaçam, Barkın Kültürsay, Azmican Kaya, Seda Tanyeri, Deniz Mutlu, Süleyman Çagan Efe, Çağdaş Bulus, Gülümser Sevgin Halil, Halit Eminoğlu, Kaan Kırali, et al.

    Background Left atrial (LA) remodeling and dysfunction are increasingly recognized as important contributors to outcomes in heart failure; however, their prognostic and functional relevance in advanced heart failure (AHF) remains insufficiently defined. This study evaluated the prognostic and functional significance of echocardiographic LA indices in AHF. Methods Between 2021 and 2023, 194 patients with left ventricular ejection fraction ≤ 25% were included. All patients were referred to our tertiary cardiovascular center for evaluation of advanced therapeutic options [left ventricular assist device (LVAD) or heart transplantation] and underwent echocardiography, right heart catheterization, and cardiopulmonary exercise testing (CPET). Kaplan-Meier and Cox regression analyses were used to assess the prognostic impact of LA strain and mechanical indices on the composite endpoint of all-cause death, LVAD implantation, or heart transplantation. Correlations with CPET parameters were examined to evaluate functional relevance. Results Patients with impaired LA reservoir strain (LASr < 8.35%) exhibited more advanced atrial remodeling, higher filling pressures, worse ventricular function, and reduced exercise capacity. During a median follow-up of 461 days, adverse outcomes occurred more frequently in the lower LASr group (35.1% vs. 14.4%, p = 0.002). Both LASr and LA minimum volume index (LAVImin) independently predicted the composite endpoint and provided incremental prognostic value. LASr, LA ejection fraction (LAEF), and LA expansion index (LAEI) showed positive associations with peak VO₂ (all p < 0.001), indicating an association between atrial mechanics and exercise performance. Conclusions In patients with AHF, LASr and LAVImin are independently associated with adverse clinical outcomes and reduced exercise tolerance. Incorporation of LA functional assessment into routine evaluation may help improve risk stratification and support clinical decision-making in this high-risk population.


  • The Recruitment of Systemic-to-Pulmonary Arterial Collaterals in Chronic and Severe Precapillary Pulmonary Hypertension as an Adaptive or Misguided Mechanism

    by Cihangir Kaymaz, Hacer Ceren Tokgöz, Barkın Kültürsay, Seda Tanyeri, Çağdaş Bulus, Çağlar Emre Çağlıyan, Müge Ildızlı Demirbaş, Metehan Kibar, Berhan Keskin, Aykun Hakgör, et al.

    Background: The clinical impact of systemic-to-pulmonary arterial collaterals (SPCs) across pulmonary hypertension (PH) groups remains unclear. The authors evaluated the prevalence, clinical correlates, and prognostic relevance of SPCs in a comprehensive PH cohort. Methods: The authors retrospectively analyzed 434 adult PH patients diagnosed per European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines. Baseline risk was evaluated using multiparametric risk scores. All patients underwent diagnostic heart catheterization and angiography, with SPC recruitment semi-quantitatively graded from 0 (none) to 3 (severe, high grade: 2-3). Results: Mean age was 51.9 ± 18.2 years (61.1% female; groups 1, 2, 3, and 4 comprised 51.6%, 3.4%, 10.1%, and 33.2%, respectively). High-grade SPCs were significantly more prevalent in group 4 (58.3%) compared to groups 1 (30.4%), 2 (20.0%), and 3 (6.8%) (P

  • Is It Time to Pay Attention to Right and Left Ventricular Apical Angles as Clinically Relevant Computed Tomography Measures in Acute Pulmonary Embolism?

    by Barkın Kültürsay, Cihangir Kaymaz, Yiğit Cengiz Erkuş, Bahadir Erdem Öcal, Seda Tanyeri Üzel, Hacer Ceren Tokgöz, Çağlar Emre Çağlıyan, Berhan Keskin, Çağdaş Buluş, Doğan Şen, et al.

    Background: In acute pulmonary embolism (PE), abrupt right ventricular (RV) pressure overload and ventricular interdependence are primary determinants of hemodynamic deterioration and short-term mortality. Conventional computed tomographic pulmonary angiography (CTPA) markers, such as the RV/left ventricular (LV) diameter ratio, exhibit variable prognostic performance and may not fully capture early geometric remodeling. It was hypothesized that CTPA-derived apical angle metrics, reflecting biventricular geometric distortion, provide complementary prognostic information beyond established clinical scores. Methods: In this retrospective study of 535 consecutive patients with acute PE, novel CTPA-derived apical geometry metrics were evaluated: the RV apical angle (α1), the LV apical angle (α2), and their ratio (α1/ α2). The primary outcome was in-hospital mortality; long-term all-cause mortality served as the secondary outcome. Results: Higher α1 and α1/α₂ values were significantly associated with greater pulmonary arterial obstruction, severe RV dysfunction, and higher clinical risk status. In-hospital mortality increased significantly across α1 tertiles (P = .017). In multiple logistic regression models, after adjustment for the Pulmonary Embolism Severity Index (PESI) score and the conventional RV/LV diameter ratio, both α1 and α1/α₂ remained independently associated with in-hospital mortality. Adding these apical metrics to the PESI-based baseline model significantly improved prognostic accuracy, demonstrating substantial incremental value for short-term risk stratification. Mortality risk increased linearly beyond thresholds of α1>32.5° and α1/α₂ > 1.17. In multiple Cox proportional hazards analysis, no imaging-derived parameter independently predicted long-term mortality. Conclusions: Computed tomographic pulmonary angiography–derived apical angle metrics provide physiologically meaningful, continuous measures of acute RV geometric remodeling in acute PE. These metrics offer significant incremental prognostic value for in-hospital mortality beyond the PESI score and conventional CT markers.

  • Ultrasound-Assisted Catheter-Directed Thrombolysis vs. Low-Dose Intravenous Tissue-Type Plasminogen Activator Treatments in Acute Intermediate-High Risk Pulmonary Embolism: Insights from a Retrospective Study

    by Cihangir Kaymaz, Barkın Kültürsay, Hacer Ceren Tokgöz, Seda Tanyeri, Berhan Keskin, Çağdaş Buluş, Çağlar Emre Çağlıyan, Deniz Mutlu, Simay Erdal, Faruk Akalın, et al.

    Background: Comparative data on ultrasound-assisted catheter-directed thromboly-sis (USAT) and systemic low-dose tissue-type plasminogen activator (tPA) for intermediate-high-risk (IHR) pulmonary embolism (PE) remain limited. The efficacy and safety outcomes of USAT vs. intravenous (IV) low-dose tPA were evaluated in this population. Methods: This study enrolled 329 IHR PE patients treated with USAT (n = 205) or IV low-dose tPA (n = 124). Post-treatment changes in clot burden (Qanadli score), right ventricular (RV) strain, and long-term mortality (median follow-up 95.8 months) were assessed. Propensity score analysis with inverse probability weighting (IPW) was employed to adjust for confounders. Results: Ultrasound-assisted catheter-directed thrombolysis was predominantly bilateral (82.9%), with a mean tPA dose of 38.5 ± 13.6 mg. In the IV tPA cohort, 58.9% required a second infusion to achieve stabilization. While IV tPA was associated with more pronounced early reductions in heart rate and RV/LV (left ventricle) ratio, USAT provided significantly greater thrombus resolution (all P < .005). After IPW adjustment, USAT demonstrated clear superiority over IV tPA in reducing residual clot burden (P < .001). However, improvements in oxygen saturation, tricuspid annular plane systolic excursion , and pulmonary artery systolic pressure (PASP) were comparable. No significant differences were observed in in-hospital mortality, PE recurrence, or long-term survival between cohorts. Higher PE severity indexes scores independently predicted in-hospital adverse events, whereas older age, male sex, and higher discharge PASP were predictors of shortened long-term survival. Conclusions: In IHR PE, IV low-dose tPA relates to more pronounced early hemodynamic and RV diameter improvements, whereas USAT achieves superior thrombus resolution. Despite these divergent surrogate responses, both strategies yield comparable early and long-term clinical outcomes, supporting their roles as viable reperfusion options.

  • Open Access

    DK‐Crush or Mini‐Crush Stenting for Complex Left Main Bifurcation Lesions: The Multicenter EVOLUTE‐CRUSH LM Registry

    by Fatih Uzun, Ahmet Güner, Aykun Hakgör, Elnur Alizade, Mehmet B. Karataş, Gökhan Alıcı, Ahmet Y. Çizgici, İrFan Şahin, İlKer Gül, Hamdi Püşüroğlu, et al.

    Background: The comparison of outcomes of mini‐crush (MCT) versus double kissing crush (DKC) techniques for complex left main bifurcation (LMB) lesions is still lacking. This investigation aimed to assess the long‐term outcomes of patients who underwent MCT or DKC for LMB disease. Methods: From 2014 to 2024, patients who underwent percutaneous coronary intervention for complex LMB lesions were retrospectively collected. The primary end point was major adverse cardiac events as the combination of cardiac death, target vessel myocardial infarction, or clinically driven target lesion revascularization during follow‐up. The secondary end point was measured as major adverse cardiovascular and cerebral events including all‐cause death, target vessel revascularization, target vessel myocardial infarction, stent thrombosis, and stroke. Results: This large‐scale multicenter (n=13) observational study included a total of 531 consecutive patients (men: 405 [76.3%], mean age: 63.16±11.26 years) with complex LMB lesions who underwent percutaneous coronary intervention. The initial revascularization strategy was MCT in 313 (59%) patients and DKC in 218 (41%) patients. The number of balloons used (5.91±1.53 versus 6.72±1.70, P P P =0.169) and major adverse cardiovascular and cerebral events (HR, 0.660; P =0.079) did not differ in individuals with complex LMB lesions treated with MCT and DKC. Other end points were also comparable between the 2 groups. Conclusions: In complex LMB lesions, risk‐adjusted major adverse cardiac events and major adverse cardiovascular and cerebral events rates were comparable between both techniques, with a nonsignificant trend favoring DKC at long‐term follow‐up. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT06546748.


  • Open Access

    18. Deep Dive into the Cardio-Pulmonary-Renal Interactions in Patients with Pulmonary Hypertension: Serum Creatinine Levels Even Within the Normal Range Related to Long-Term Survival

    by Hacer Ceren Tokgöz, Aykun Hakgör, Seda Tanyeri Üzel, Barkın Kültürsay, Ahmet Sekban, Berhan Keskin, Ayhan Tosun, Çağdaş Buluş, Dicle Sırma, Şeyhmus Külahçıoğlu, et al.

    Background: Renal function in patients with pulmonary hypertension (PH) can be disrupted due to hypotension, low cardiac output, and venous pressure overload because of the its dependency on the pressure gradient between systemic arterial and venous circulations. The aim was to investigate whether measures of venous and pulmonary circulations determine renal function in patients with PH. Methods: The single-center study group comprised 1071 patients with a hemodynamically confirmed PH diagnosis. Serum creatinine level was used for surrogate of renal perfusion status. Echocardiographic measures included left ventricle ejection fraction (LVEF), tricuspid annular plane excursion (TAPSE), and right atrial area (RAA). Hemodynamic parameters included mean aortic and pulmonary pressures (MAP and PAMP), pulmonary capillary wedge (PCWP) and right atrial pressure (RAP), transsystemic and transpulmonary pressure gradients (TSG and TPG), and pulmonary and systemic vascular resistances (PVR and SVR), respectively. Results: Serum creatinine was significantly associated with TSG, RAP, TPG, PAMP, PVR, PVR/SVR ratio, cardiac index, stroke volume index, mixed venous O2 Sat %, TAPSE, RAA, LVEF%, pericardial effusion and BNP/NT-ProBNP levels (P < .05 for all), but not with MAP, PCWP, and SVR. According to the creatinine tertiles, survival rates were significantly different between groups 1 vs. 3, and 2 vs. 3 (P = .001 for both). Conclusion: An integrative approach regarding cardio-pulmonary-renal interactions seems to provide a comprehensive perspective for circulatory status and renal function in patients with PH and congestive heart failure. More importantly, even small increases of serum creatinine levels within the normal range seems to be associated long-term survival differences.


  • Open Access

    Ultrasound-Assisted Catheter-Directed Thrombolytic Therapy Vs. Anticoagulation in Acute Intermediate-High Risk Pulmonary Embolism: A Quasi-Experimental Study

    by Barkın Kültürsay, Berhan Keskin, Seda Tanyeri, Hacer Ceren Tokgöz, Aykun Hakgör, Çağdaş Buluş, Deniz Mutlu, Ahmet Sekban, Dicle Sırma, Şeyhmus Külahçıoğlu, et al.

    Background: Given the bleeding risk associated with full-dose intravenous thrombolytic treatment and the absence of randomized clinical trial evidence, current guidelines do not recommend reperfusion treatments as first-line therapy for intermediate-high risk (IHR) pulmonary embolism (PE). The aim of this study was to evaluate the effectiveness and safety of ultrasound-assisted catheter-directed thrombolysis (USAT) compared to anticoagulation therapy alone in patients with IHR PE. Methods: A total of 425 patients diagnosed with acute PE and determined as IHR, 203 of whom underwent USAT, and 222 patients receiving only anticoagulants as the control group, were included. Baseline and post-treatment right ventricle (RV) function in echocardiography, tomographic RV/left ventricle (RV/LV) ratio, Qanadli score (Qs), and % changes from baseline were taken as primary effectiveness outcomes. For safety outcomes, major and minor bleeding and in-hospital all-cause death were adopted. Propensity score analysis was performed to reduce confounders and bias. Results: The USAT treatment was found to be associated with improved RV function and decreased Qs, but no significant effect was observed on the RV/LV ratio and its change. Bleeding events were more frequent in the USAT group (P < .001 for both), and no difference was observed in terms of mortality. Conclusion: The study, based on real-life data, has shown that a moderate-dose, slow-infusion tissue-type plasminogen activator regimen is superior to anticoagulant therapy alone in terms of reducing pulmonary arterial thrombus burden, restoring RV dysfunction, and improving clinical outcomes in acute PE patients at IHR. However, it has also resulted in a slight increase in bleeding events.